Deciphering the Warburg Effect: Metabolic Reprogramming, Epigenetic Remodeling, and Cell Dedifferentiation

被引:5
|
作者
Li, Albert M. [1 ,2 ,3 ]
Ye, Jiangbin [2 ,4 ]
机构
[1] Stanford Univ, Dept Radiat Oncol, Sch Med, Stanford, CA 94305 USA
[2] Stanford Univ, Canc Biol Program, Sch Med, Stanford, CA 94305 USA
[3] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst, Program Immunol, New York, NY 10065 USA
[4] Stanford Univ, Stanford Canc Inst, Sch Med, Stanford, CA USA
来源
关键词
Warburg effect; cancer metabolism; differentiation; epigenetics; mitochondria uncoupling; symbiogenesis; GASTROINTESTINAL STROMAL TUMORS; MITOCHONDRIAL PYRUVATE CARRIER; FUMARATE-HYDRATASE; DNA DEMETHYLATION; ACETATE SUPPLEMENTATION; SPONTANEOUS REGRESSION; HISTONE DEMETHYLATION; GENE-EXPRESSION; IDH2; MUTATIONS; SDH MUTATIONS;
D O I
10.1146/annurev-cancerbio-062822-120857
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
A century ago, Otto Heinrich Warburg made a seminal discovery now known as the Warburg effect. This metabolic signature, prevalent across all cancer cells, is characterized by the prominent shift of glucose metabolism toward lactate production instead of oxidative respiration. Warburg's pioneering theory suggested that the induction of the Warburg effect instigates dedifferentiation and the process of tumorigenesis, illuminating a fundamental mechanism underlying cancer development. To celebrate the centennial anniversary of Warburg's monumental finding, it is an appropriate moment to reflect upon and commemorate his revolutionary contributions to the fields of metabolism and cancer research. In this review, we explore the role of mitochondria in epigenetic regulation and the decisions governing cell fate from an evolutionary standpoint. Moreover, we summarize metabolic and genetic factors that trigger the Warburg effect, underscoring the therapeutic potential of mitochondrial uncoupling as a strategy to counter this metabolic aberration. Our goal is to elucidate the means to induce tumor differentiation through metabolic therapy, thereby laying a foundation toward the cure for cancer.
引用
收藏
页码:35 / 58
页数:24
相关论文
共 50 条
  • [41] Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming
    Kuniyuki Aso
    Michihito Kono
    Masatoshi Kanda
    Yuki Kudo
    Kodai Sakiyama
    Ryo Hisada
    Kohei Karino
    Yusho Ueda
    Daigo Nakazawa
    Yuichiro Fujieda
    Masaru Kato
    Olga Amengual
    Tatsuya Atsumi
    Nature Communications, 14
  • [42] Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming
    Aso, Kuniyuki
    Kono, Michihito
    Kanda, Masatoshi
    Kudo, Yuki
    Sakiyama, Kodai
    Hisada, Ryo
    Karino, Kohei
    Ueda, Yusho
    Nakazawa, Daigo
    Fujieda, Yuichiro
    Kato, Masaru
    Amengual, Olga
    Atsumi, Tatsuya
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [43] Epigenetic regulation of somatic cell reprogramming
    Wang, Yixuan
    Bi, Yan
    Gao, Shaorong
    CURRENT OPINION IN GENETICS & DEVELOPMENT, 2017, 46 : 156 - 163
  • [44] Hypoxia in Cell Reprogramming and the Epigenetic Regulations
    Nakamura, Nariaki
    Shi, Xiaobing
    Darabi, Radbod
    Li, Yong
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [45] Metabolic Controls on Epigenetic Reprogramming in Regulatory T Cells
    Lu, Jingli
    Liang, Yan
    Meng, Haiyang
    Zhang, Ailing
    Zhao, Junjie
    Zhang, Chengliang
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] Epigenetic and metabolic reprogramming as a target for prostate tumor radiosensitization
    Dubrovska, A.
    Peitzsch, C.
    Tyutyunnykova, A.
    Cojoc, M.
    RADIOTHERAPY AND ONCOLOGY, 2017, 123 : S201 - S201
  • [47] Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer
    Yu, Xian
    Ma, Rui
    Wu, Yinsheng
    Zhai, Yansheng
    Li, Shanshan
    FRONTIERS IN GENETICS, 2018, 9
  • [48] Epigenetic and metabolic reprogramming of SDH-deficient paragangliomas
    Moog, Sophie
    Lussey-Lepoutre, Charlotte
    Favier, Judith
    ENDOCRINE-RELATED CANCER, 2020, 27 (12) : R451 - R463
  • [49] Epigenetic reprogramming in metabolic disorders: nutritional factors and beyond
    Cheng, Zhiyong
    Zheng, Louise
    Almeida, Fabio A.
    JOURNAL OF NUTRITIONAL BIOCHEMISTRY, 2018, 54 : 1 - 10
  • [50] Metabolic regulation of epigenetic remodeling in immune cells
    Britt, Emily C.
    John, Steven V.
    Locasale, Jason W.
    Fan, Jing
    CURRENT OPINION IN BIOTECHNOLOGY, 2020, 63 : 111 - 117